acm global central laboratory limited

Live MatureLargeRapid

acm global central laboratory limited Company Information

Share ACM GLOBAL CENTRAL LABORATORY LIMITED

Company Number

03809941

Shareholders

acm global central laboratory operations ltd

Group Structure

View All

Industry

Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.

 

Registered Address

23 hospital fields road, york, north yorkshire, YO10 4DZ

acm global central laboratory limited Estimated Valuation

£18.7m

Pomanda estimates the enterprise value of ACM GLOBAL CENTRAL LABORATORY LIMITED at £18.7m based on a Turnover of £24.2m and 0.77x industry multiple (adjusted for size and gross margin).

acm global central laboratory limited Estimated Valuation

£19.7m

Pomanda estimates the enterprise value of ACM GLOBAL CENTRAL LABORATORY LIMITED at £19.7m based on an EBITDA of £3.7m and a 5.28x industry multiple (adjusted for size and gross margin).

acm global central laboratory limited Estimated Valuation

£24m

Pomanda estimates the enterprise value of ACM GLOBAL CENTRAL LABORATORY LIMITED at £24m based on Net Assets of £10.7m and 2.24x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Acm Global Central Laboratory Limited Overview

Acm Global Central Laboratory Limited is a live company located in north yorkshire, YO10 4DZ with a Companies House number of 03809941. It operates in the other professional, scientific and technical activities n.e.c. sector, SIC Code 74909. Founded in July 1999, it's largest shareholder is acm global central laboratory operations ltd with a 100% stake. Acm Global Central Laboratory Limited is a mature, large sized company, Pomanda has estimated its turnover at £24.2m with rapid growth in recent years.

View Sample
View Sample
View Sample

Acm Global Central Laboratory Limited Health Check

Pomanda's financial health check has awarded Acm Global Central Laboratory Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 9 measures and has 1 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating5out of 5
positive_score

9 Strong

positive_score

2 Regular

positive_score

1 Weak

size

Size

annual sales of £24.2m, make it larger than the average company (£2.9m)

£24.2m - Acm Global Central Laboratory Limited

£2.9m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 34%, show it is growing at a faster rate (7.2%)

34% - Acm Global Central Laboratory Limited

7.2% - Industry AVG

production

Production

with a gross margin of 30.4%, this company has a higher cost of product (45%)

30.4% - Acm Global Central Laboratory Limited

45% - Industry AVG

profitability

Profitability

an operating margin of 13% make it more profitable than the average company (5.6%)

13% - Acm Global Central Laboratory Limited

5.6% - Industry AVG

employees

Employees

with 150 employees, this is above the industry average (23)

150 - Acm Global Central Laboratory Limited

23 - Industry AVG

paystructure

Pay Structure

on an average salary of £41.8k, the company has a lower pay structure (£54k)

£41.8k - Acm Global Central Laboratory Limited

£54k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £161.5k, this is more efficient (£125.4k)

£161.5k - Acm Global Central Laboratory Limited

£125.4k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 26 days, this is earlier than average (56 days)

26 days - Acm Global Central Laboratory Limited

56 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 32 days, this is close to average (31 days)

32 days - Acm Global Central Laboratory Limited

31 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 13 days, this is less than average (30 days)

13 days - Acm Global Central Laboratory Limited

30 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 25 weeks, this is average cash available to meet short term requirements (24 weeks)

25 weeks - Acm Global Central Laboratory Limited

24 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 44.3%, this is a lower level of debt than the average (53.3%)

44.3% - Acm Global Central Laboratory Limited

53.3% - Industry AVG

ACM GLOBAL CENTRAL LABORATORY LIMITED financials

EXPORTms excel logo

Acm Global Central Laboratory Limited's latest turnover from December 2023 is £24.2 million and the company has net assets of £10.7 million. According to their latest financial statements, Acm Global Central Laboratory Limited has 150 employees and maintains cash reserves of £4.1 million as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Turnover24,225,16719,962,85614,386,76010,061,32013,106,42318,861,72828,656,13318,876,30613,101,26614,044,20210,912,39212,423,41910,146,3575,346,1076,153,411
Other Income Or Grants
Cost Of Sales16,852,49615,535,99911,384,8889,482,02011,841,76216,456,24221,880,72913,729,59010,317,89410,547,7407,464,8458,133,1526,796,0093,513,1143,688,415
Gross Profit7,372,6714,426,8573,001,872579,3001,264,6612,405,4866,775,4045,146,7162,783,3723,496,4623,447,5474,290,2673,350,3481,832,9932,464,996
Admin Expenses4,219,3412,458,4173,081,5742,752,7212,833,1792,645,9823,251,6551,940,4602,156,9652,060,2271,929,4192,312,4401,848,4601,690,4411,633,755
Operating Profit3,153,3301,968,440-79,702-2,173,421-1,568,518-240,4963,523,7493,206,256626,4071,436,2351,518,1281,977,8271,501,888142,552831,241
Interest Payable9,00012,0006,433151,9651,8502,4332,7848,693
Interest Receivable185,776167,235151,567158,300160,827138,030106,47582,88050,90315,1001396
Pre-Tax Profit3,339,1062,135,675-261,141-2,024,121-1,419,691-108,8993,630,2243,289,136677,3101,451,3201,516,1631,975,9771,499,455139,769822,944
Tax-723,072-355,160115,17857,34474,025-781,650-476,04544,340-35,643-95,603-222,256-163,96773,938-12,428
Profit After Tax2,616,0341,780,515-145,963-2,024,121-1,362,347-34,8742,848,5742,813,091721,6501,415,6771,420,5601,753,7211,335,488213,707810,516
Dividends Paid5,000,000
Retained Profit2,616,0341,780,515-145,963-2,024,121-1,362,347-34,8742,848,5742,813,091721,6501,415,6771,420,560-3,246,2791,335,488213,707810,516
Employee Costs6,265,0695,366,8444,593,0274,016,3954,169,9785,059,8785,278,3113,874,4323,396,7322,575,2972,118,1402,387,6851,998,2081,496,7811,478,698
Number Of Employees150133125122127160161110978275654650
EBITDA*3,731,6282,607,819532,804-1,737,623-1,172,016105,6373,803,0653,363,202781,9261,566,0071,643,5052,039,5561,537,961174,890874,100

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Tangible Assets1,529,0521,721,2261,962,6742,166,1331,240,4301,354,7281,407,3541,052,566603,646670,322599,282699,33987,94182,19094,312
Intangible Assets333,006
Investments & Other22221,238,4561,238,456
Debtors (Due After 1 year)5,955,9205,606,8694,696,9914,591,2504,510,2324,448,0463,036,6212,680,6061,548,742924,189
Total Fixed Assets7,484,9747,328,0976,659,6677,090,3916,989,1187,041,2304,443,9753,733,1722,152,3881,594,511599,282699,33987,94182,19094,312
Stock & work in progress616,249767,950791,018672,176477,894389,466450,259370,686277,846276,314213,055176,461161,452162,765155,399
Trade Debtors1,733,3882,223,3782,002,768900,3041,150,2691,499,0523,208,0522,178,1871,701,1051,450,392712,5571,300,6782,201,334832,728527,293
Group Debtors3,051,5621,528,516309,172383,5571,429,399450,4221,167,1621,264,198403,655559,449630,5161,754,6161,666,2342,028,129
Misc Debtors2,245,3403,095,5562,708,0182,566,7242,519,9392,557,5441,964,4101,573,5621,115,0031,050,2751,085,853933,474325,088223,688113,476
Cash4,056,0591,848,3351,186,726177,794246,790467,4312,076,3351,246,292884,1771,318,3611,417,538396,6781,731,471559,151393,069
misc current assets
total current assets11,702,5989,463,7356,997,7024,700,5555,824,2915,363,9158,866,2186,632,9254,381,7864,654,7914,059,5192,807,2916,173,9613,444,5663,217,366
total assets19,187,57216,791,83213,657,36911,790,94612,813,40912,405,14513,310,19310,366,0976,534,1746,249,3024,658,8013,506,6306,261,9023,526,7563,311,678
Bank overdraft
Bank loan
Trade Creditors 1,485,9181,718,863813,532921,640889,9771,022,5161,564,8361,459,8081,039,459942,576767,9761,074,2231,147,215468,277459,459
Group/Directors Accounts5,500,0025,500,0025,500,0022,950,0021,772,096413,21299,596239,716123,225
other short term finances
hp & lease commitments3,9385,2505,2505,250
other current liabilities1,323,4211,329,6891,048,6341,478,1401,161,205859,5951,501,0651,600,0551,026,6891,560,3501,488,8931,105,444868,195265,450267,647
total current liabilities8,309,3418,548,5547,362,1685,349,7823,823,2782,295,3233,165,4973,059,8632,066,1482,502,9262,256,8692,423,3212,143,885738,977732,356
loans300,000
hp & lease commitments3,9389,18814,438
Accruals and Deferred Income
other liabilities
provisions186,481167,56257,34457,34467,45642,33942,339113,572215,509
total long term liabilities186,481167,562300,00057,34457,34467,45642,33942,339113,572215,5093,9389,18814,438
total liabilities8,495,8228,716,1167,362,1685,349,7824,123,2782,352,6673,222,8413,127,3192,108,4872,545,2652,370,4412,638,8302,147,823748,165746,794
net assets10,691,7508,075,7166,295,2016,441,1648,690,13110,052,47810,087,3527,238,7784,425,6873,704,0372,288,360867,8004,114,0792,778,5912,564,884
total shareholders funds10,691,7508,075,7166,295,2016,441,1648,690,13110,052,47810,087,3527,238,7784,425,6873,704,0372,288,360867,8004,114,0792,778,5912,564,884
Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Operating Activities
Operating Profit3,153,3301,968,440-79,702-2,173,421-1,568,518-240,4963,523,7493,206,256626,4071,436,2351,518,1281,977,8271,501,888142,552831,241
Depreciation578,298639,379612,506424,573396,502346,133279,316156,946155,519129,772125,37761,72936,07332,33842,859
Amortisation11,225
Tax-723,072-355,160115,17857,34474,025-781,650-476,04544,340-35,643-95,603-222,256-163,96773,938-12,428
Stock-151,701-23,068118,842194,28288,428-60,79379,57392,8401,53263,25936,59415,009-1,3137,366155,399
Debtors531,8912,737,3701,275,114-1,168,004654,775-421,1811,679,6922,928,048784,2001,555,379194,774-2,046,8861,558,38853,7522,668,898
Creditors-232,945905,331-108,10831,663-132,539-542,320105,028420,34996,883174,600-306,247-72,992678,9388,818459,459
Accruals and Deferred Income-6,268281,055-429,506316,935301,610-641,470-98,990573,366-533,66171,457383,449237,249602,745-2,197267,647
Deferred Taxes & Provisions18,919167,562-57,344-10,11225,117-71,233-101,937215,509
Cash flow from operations2,408,072892,305-1,283,588-415,303-1,746,148-522,1541,258,076885,101-396,24486,5501,291,7994,228,9431,098,602194,331-1,235,519
Investing Activities
capital expenditure-386,124-397,931-76,041-1,694,507-282,204-293,507-634,104-605,866-88,843-200,812-25,320-673,127-41,824-20,216-137,171
Change in Investments-1,238,4541,238,456
cash flow from investments-386,124-397,931-76,041-456,053-282,204-1,531,963-634,104-605,866-88,843-200,812-25,320-673,127-41,824-20,216-137,171
Financing Activities
Bank loans
Group/Directors Accounts2,550,0001,177,9061,358,884313,61699,596-239,716116,491123,225
Other Short Term Loans
Long term loans-300,000300,000
Hire Purchase and Lease Commitments-3,938-5,250-5,250-5,25019,688
other long term liabilities
share issue-224,8461,754,368
interest185,776167,235151,567149,300148,827131,597106,47582,88050,90315,085-1,965-1,850-2,433-2,783-8,297
cash flow from financing185,776167,2352,701,567802,3601,807,711445,213206,07182,88050,90315,085-245,619109,391115,542-8,0331,765,759
cash and cash equivalents
cash2,207,724661,6091,008,932-68,996-220,641-1,608,904830,043362,115-434,184-99,1771,020,860-1,334,7931,172,320166,082393,069
overdraft
change in cash2,207,724661,6091,008,932-68,996-220,641-1,608,904830,043362,115-434,184-99,1771,020,860-1,334,7931,172,320166,082393,069

acm global central laboratory limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for acm global central laboratory limited. Get real-time insights into acm global central laboratory limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Acm Global Central Laboratory Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for acm global central laboratory limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other large companies, companies in YO10 area or any other competitors across 12 key performance metrics.

acm global central laboratory limited Ownership

ACM GLOBAL CENTRAL LABORATORY LIMITED group structure

Acm Global Central Laboratory Limited has 3 subsidiary companies.

Ultimate parent company

ROCHESTER REGIONAL HEALTH

#0071138

2 parents

ACM GLOBAL CENTRAL LABORATORY LIMITED

03809941

3 subsidiaries

ACM GLOBAL CENTRAL LABORATORY LIMITED Shareholders

acm global central laboratory operations ltd 100%

acm global central laboratory limited directors

Acm Global Central Laboratory Limited currently has 1 director, Mr Kenneth Babineau serving since Nov 2022.

officercountryagestartendrole
Mr Kenneth BabineauUnited Kingdom55 years Nov 2022- Director

P&L

December 2023

turnover

24.2m

+21%

operating profit

3.2m

+60%

gross margin

30.5%

+37.24%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

10.7m

+0.32%

total assets

19.2m

+0.14%

cash

4.1m

+1.19%

net assets

Total assets minus all liabilities

acm global central laboratory limited company details

company number

03809941

Type

Private limited with Share Capital

industry

74909 - Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.

incorporation date

July 1999

age

26

incorporated

UK

ultimate parent company

ROCHESTER REGIONAL HEALTH

accounts

Full Accounts

last accounts submitted

December 2023

previous names

pivotal laboratories limited (March 2009)

accountant

-

auditor

SMAILES GOLDIE & WATSONS LIMITED

address

23 hospital fields road, york, north yorkshire, YO10 4DZ

Bank

HSBC BANK PLC

Legal Advisor

-

acm global central laboratory limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 2 charges/mortgages relating to acm global central laboratory limited. Currently there are 0 open charges and 2 have been satisfied in the past.

acm global central laboratory limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for ACM GLOBAL CENTRAL LABORATORY LIMITED. This can take several minutes, an email will notify you when this has completed.

acm global central laboratory limited Companies House Filings - See Documents

datedescriptionview/download